Related Experiment Video

Updated: Jun 8, 2026

Enrichment of Mammalian Tissues and Xenopus Oocytes with Cholesterol
10:12

Enrichment of Mammalian Tissues and Xenopus Oocytes with Cholesterol

Published on: March 25, 2020

Cholesterol depletion enhances adrenergic signaling in cardiac myocytes

Yamuna Devi Paila1, Ekta Jindal, Shyamal K Goswami

  • 1Centre for Cellular and Molecular Biology, Council of Scientific and Industrial Research Uppal Road, Hyderabad 500 007, India.

Biochimica Et Biophysica Acta
|September 21, 2010
PubMed

Insights

Cholesterol levels impact cardiac cell responses to stress. Lowering cholesterol amplifies adrenergic signaling, promoting cell growth or death, while replenishment restores normal signaling pathways.

Area of Science:

  • Cardiovascular Biology
  • Cellular Signaling
  • Molecular Cardiology

Background:

  • Cardiac myocytes possess alpha and beta adrenergic receptors, crucial for G-protein coupled receptor signaling.
  • Norepinephrine exposure can trigger cardiac hypertrophy or apoptosis via AP-1 transcription factors (FosB and Fra-1).

Purpose of the Study:

  • To investigate how cellular cholesterol levels influence adrenergic signaling pathways in cardiac myocytes.
  • To understand the role of cholesterol in determining cardiac cell fate (hypertrophy vs. apoptosis).

Main Methods:

  • Utilized promoter-reporter constructs for FosB and Fra-1 to monitor adrenergic signaling.
  • Manipulated cellular cholesterol levels through depletion and replenishment.
  • Administered specific ligands for alpha and beta adrenergic receptors.

Main Results:

  • Cholesterol depletion significantly enhanced norepinephrine-mediated signaling in cardiac myocytes.
  • This enhanced signaling returned to baseline levels upon cholesterol replenishment.
  • The augmented signaling observed during cholesterol depletion resulted from the combined action of both alpha and beta adrenergic receptors.

Conclusions:

  • Cellular cholesterol content plays a critical role in modulating adrenergic signaling intensity in cardiac myocytes.
  • Cholesterol levels act as a switch, influencing the cell's decision between hypertrophy and apoptosis.
  • This study provides direct evidence linking cholesterol levels to adrenergic signaling outcomes at the gene expression level.

More Related Videos

Measuring the Rate of Lipolysis in Ex Vivo Murine Adipose Tissue and Primary Preadipocytes Differentiated In Vitro09:41

Measuring the Rate of Lipolysis in Ex Vivo Murine Adipose Tissue and Primary Preadipocytes Differentiated In Vitro

Published on: March 17, 2023

Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice07:36

Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice

Published on: September 26, 2018

Related Concept Videos

Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Sympathetic Signaling01:31

Sympathetic Signaling

Sympathetic signaling, a vital part of the autonomic nervous system, plays a crucial role in mobilizing the body's resources in response to stress or emergencies. It involves the transmission of nerve impulses from sympathetic preganglionic fibers to postganglionic fibers. This results in the release of specific neurotransmitters and activation of adrenergic receptors.
Sympathetic preganglionic fibers release the neurotransmitter acetylcholine (ACh) onto the ganglionic neurons in the...
Adrenergic Agonists: Direct-Acting Agents01:30

Adrenergic Agonists: Direct-Acting Agents

Drugs that mimic the action of endogenous catecholamines like noradrenaline and adrenaline are called adrenergic agonists or sympathomimetics. Based on their mechanism of action, sympathomimetics can be classified as direct-, indirect-, or mixed-acting sympathomimetics. Direct-acting adrenergic agonists activate adrenoceptors without affecting presynaptic neurons, making them independent of neuronal catecholamine-depleting agents like reserpine and guanethidine.
These agents can be classified...
Adrenergic Receptors (Adrenoceptors): Classification01:27

Adrenergic Receptors (Adrenoceptors): Classification

Adrenergic receptors, or adrenoceptors, respond to the autonomic neurotransmitter noradrenaline and other endogenous catecholamine agonists. They are classified into two main families, α and β, based on their pharmacological response and are further subdivided depending on their location, elicited response, and affinity to specific agonists or antagonists.
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors, which are found on postsynaptic...
G-Protein Gated Ion Channels01:21

G-Protein Gated Ion Channels

GPCRs are primarily responsible for our sense of smell, taste, and vision.  The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory organs,...
Adrenergic Agonists: Indirect-Acting Agents01:25

Adrenergic Agonists: Indirect-Acting Agents

Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...